ILMN Illumina Inc

Illumina Inc engages in life science tools and machines for analyzing genetic material. The company primarily engages in microarray and genome sequencing machines and disposables. It also provides sequencing services through its products.

$371.05  -1.79 (-0.48%)
As of 05/13/2021 11:08:59 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Large cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  02/20/2001
Outstanding shares:  146,000,000
Average volume:  802,752
Market cap:   $55,547,160,000
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    452327109
ISIN:        US4523271090
Sedol:      2613990

---

Valuation   (See tab for details)

---

PE ratio:   88.41
PB ratio:   11.32
PS ratio:   9.65
Return on equity:   20.91%
Net income %:   17.87%